Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies

Immunotherapy. 2013 Nov;5(11):1147-50. doi: 10.2217/imt.13.115.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Animals
  • Cancer Vaccines* / immunology
  • Cancer Vaccines* / therapeutic use
  • Clinical Trials as Topic
  • Glioma* / immunology
  • Glioma* / therapy
  • Humans
  • Immunotherapy*
  • Portraits as Topic

Substances

  • Cancer Vaccines